Calton & Associates’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History
Bought
Maintained
Sold
Other funds holding ECAT
SCM
PCM
AAM
Calton & Associates's ECAT Position: Q3 2025 in Review
Calton & Associates sold out of BlackRock ESG Capital Allocation Term Trust (ECAT) in Q3 2025, closing a stake of 12,543 shares — an estimated $201K sold.
Calton & Associates first reported a position in ECAT in Q2 2022 and held it in 12 quarters. The position peaked at $365K in Q1 2023. 74 funds tracked by Wall St. Rank hold ECAT as of Q3 2025.
- Calton & Associates reported no remaining BlackRock ESG Capital Allocation Term Trust position as of Q3 2025 after selling out during the quarter.
- Calton & Associates sold 12,543 BlackRock ESG Capital Allocation Term Trust shares in Q3 2025, an estimated $201K.
- Calton & Associates first reported a position in BlackRock ESG Capital Allocation Term Trust in Q2 2022 and held it in 12 quarters.
- Calton & Associates's BlackRock ESG Capital Allocation Term Trust position peaked at $365K in Q1 2023.
- 74 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q3 2025.
Based on Calton & Associates's 13F filing for Q3 2025, filed 7 Nov 2025.